BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 9, Issue 21
  • This Article
Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (12204)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.
Item 
Count 
PDF803
WORD235
HTML6586
Figures (1-2)1023
Tables (1-2)583
 Sum=9230
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse741
Download2223
 Sum=2964
Jul 26, 2021 (publication date) through Mar 28, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Shih CA, Chen WC. Prevention of hepatitis B reactivation in patients requiring chemotherapy and immunosuppressive therapy. World J Clin Cases 2021; 9(21): 5769-5781 [PMID: 34368296 DOI: 10.12998/wjcc.v9.i21.5769]
URL: https://www.wjgnet.com/1007-9327/full/v9/i21/5769.htm
Number Citing Articles
1
Jia-Rui Zheng, Zi-Long Wang, Bo Feng. Hepatitis B functional cure and immune response. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1075916
2
Galina I. Gridneva, Boris S. Belov, Evgeniia S. Aronova. Chronic hepatitis B in rheumatic diseases: issues of screening and reactivation of infection: A review. Terapevticheskii arkhiv 2024; 96(5): 523 doi: 10.26442/00403660.2024.05.202707
3
Sara Lacerda Pereira, Raquel Duro, António Sarmento. Late Hepatitis B reactivation after treatment with rituximab. IDCases 2022; 27: e01393 doi: 10.1016/j.idcr.2022.e01393
4
Peter D. Block, David N. Assis. Hepatotoxicity of Chemotherapy and Immune Checkpoint Inhibitors. Clinics in Liver Disease 2025; 29(3): 483 doi: 10.1016/j.cld.2025.03.006
5
Tânia Lourenço, Nuno Vale. Entecavir: A Review and Considerations for Its Application in Oncology. Pharmaceuticals 2023; 16(11): 1603 doi: 10.3390/ph16111603
6
Chunyan Yuan, Jing Peng, Renxiang Xia, Jian He, Tianji Qiu, Yunqing Yao. Reactivation of Occult Hepatitis B Virus Infection During Long-Term Entecavir Antiviral Therapy. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.865124
7
Lidawani Lambuk, Aina Akmal Mohd Noor, Fatmawati Lambuk, Tuan Noorkorina Tuan Kub, Muhammad Zulfiqah Sadikan, Norhayati Yusop, Rohimah Mohamud, Nik Haszroel Hysham Nik Hashim. Navigating the landscape of hepatitis B virus reactivation in HBsAg-positive and HBsAg-negative resolved infections: Current insights and future directions. The American Journal of the Medical Sciences 2026; 371(2): 188 doi: 10.1016/j.amjms.2025.10.012
8
Mariana Cavalheiro Magri, Victória Gonçalves de Paula, Marina Rossi de Camargo Pinto, Débora Bignotto Rosane Battaglia, Rafael de Oliveira, Gustavo Manoel Ferreira, Fátima Mitiko Tengan, Edson Abdala. Prevalence of vaccine-induced immunity to hepatitis B in cancer patients: A 13-year analysis in a quaternary oncological center. Cancer Epidemiology 2025; 99: 102946 doi: 10.1016/j.canep.2025.102946
9
Ahmad Al-Bitar, Israa Tellawi, Hazem Kamil, Dana Al-Masalma, Karam Jeji, Souheb Al-mahasna. Synchronous triple-negative breast cancer, rectal adenocarcinoma, and chemotherapy-induced hepatitis B virus reactivation: a case report and review of the literature. Journal of Medical Case Reports 2025; 19(1) doi: 10.1186/s13256-025-05423-8
10
Tadesse Atanaw, Getu Girmay, Aragaw Zemene, Muluneh Assefa, Tewodros Eshetie, Gezahegn Bewket, Fikadu Alemiye, Debaka Belete, Nega Birhane, Miquel Vall-llosera Camps. Seroprevalence of hepatitis B and C viruses and some possible associated factors among cancer patients at the Oncology Treatment Center, Gondar, Northwest Ethiopia: A cross-sectional study. PLOS ONE 2024; 19(8): e0308161 doi: 10.1371/journal.pone.0308161
11
Ali A. Younis, Ahmed A. Ahmed Al-Harbi. Juvenile dermatomyositis and hepatitis B viral infection. European Journal of Case Reports in Internal Medicine 2025; 12(5) doi: 10.12890/2025_005372
12
Caterina Sagnelli, Antonello Sica, Massimiliano Creta, Alessandra Borsetti, Massimo Ciccozzi, Evangelista Sagnelli. Prevention of HBV Reactivation in Hemato-Oncologic Setting during COVID-19. Pathogens 2022; 11(5): 567 doi: 10.3390/pathogens11050567
13
Natee Deepan, Soe Thiha Maung, Pakanat Decharatanachart, Roongruedee Chaiteerakij. Hepatitis B Virus Reactivation in Cancer Patients Receiving Chemotherapy—A Systematic Review and Meta-Analysis. Seminars in Oncology 2024; 51(5-6): 123 doi: 10.1053/j.seminoncol.2024.08.001
14
Serena Zaltron, Anna Cambianica, Marco Di Gregorio, Cosimo Colangelo, Samuele Storti, Giorgio Tiecco, Francesco Castelli, Eugenia Quiros-Roldan. Case report: An occult hepatitis B virus infection reactivation in an HIV/HCV coinfected patient during an immune reconstitution inflammatory syndrome. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1143346
15
Mustafa Gürbüz, Deniz Tural, Timuçin Çil, Hacer Demir, Osman Köstek, Özlem Nuray Sever, İmdat Eroğlu, İzzet Doğan, Mehmet Ali Nahit Şendur, Çağatay Arslan, Emre Akar, Elif Berna Köksoy, İsmail Beypınar, İrfan Çiçin, Şahin Laçin, Didem Taştekin, Güngör Utkan, Lokman Koral, Semra Paydaş, İsa Dede, Ahmet Ziya Bayhan, Muhammet Ali Kaplan, Özgür Tanrıverdi, Saadettin Kılıçkap, Yüksel Ürün. Prevalence and Reactivation of Hepatitis B and C in Patients Undergoing Chemotherapy for Solid Tumors. JCO Global Oncology 2026; 12(3) doi: 10.1200/GO-25-00234
16
Adeniyi Abraham Adesola, Matei-Alexandru Cozma, Yong-Feng Chen, Bahadar Singh Srichawla, Mihnea-Alexandru Găman. Risk of hepatitis B reactivation in patients with myeloproliferative neoplasms treated with ruxolitinib. World Journal of Hepatology 2023; 15(11): 1188-1195 doi: 10.4254/wjh.v15.i11.1188
17
Jiajia Hu, Jie Zhao, Chunyan Wang, Mei Jia, Ming Su, Shanshan Li. Epstein–Barr virus reactivation correlates with worse outcomes for patients exposed to hepatitis B virus after haploidentical hematopoietic stem cell transplantation. Annals of Hematology 2023; 102(12): 3593 doi: 10.1007/s00277-023-05492-z
18
Shahrzad Shoraka, Seyed Reza Mohebbi, Seyed Masoud Hosseini, Amir Ghaemi, Mohammad Reza Zali. SARS-CoV-2 and chronic hepatitis B: Focusing on the possible consequences of co-infection. Journal of Clinical Virology Plus 2023; 3(4): 100167 doi: 10.1016/j.jcvp.2023.100167
19
Zahra Dossaji, Lubaba Haque, Adam Khattak, Mark Hsu, Robert Gish. A Review of Hepatitis B Reactivation Risk on Immunosuppressants with a Focus on Newer Immunomodulators. Current Hepatology Reports 2024; 23(2): 253 doi: 10.1007/s11901-024-00662-7
20
Jennifer Leigh, Ranjeeta Mallick, Stephanie Brule, Lisa Rambout, Jennifer Newton, Dominick Bossé, Curtis Cooper, Joanna Gotfrit. Implementation of a Hepatitis B Screening Program in Patients Receiving Systemic Anti-Cancer Therapy. Current Oncology 2024; 32(1): 20 doi: 10.3390/curroncol32010020
Write to the Help Desk
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345